1. Show article details.

    BRIEF-Stryker Announces Definitive Agreement To Acquire Mobius Imaging & Cardan Robotics

    Reuters – 8:10 AM ET 09/04/2019

    Stryker Corp (SYK): * STRYKER ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE MOBIUS IMAGING & CARDAN ROBOTICS. * Stryker Corp (SYK) - DEAL FOR ALL CASH OF ABOUT $370 MILLION UPFRONT AND UP TO $130 MILLION OF CONTINGENT PAYMENTS. * Stryker Corp (SYK) - TRANSACTION IS EXPECTED TO HAVE AN IMMATERIAL IMPACT TO NET EARNINGS IN 2019 Source text for Eikon: Further company coverage:

  2. Show article details.

    Stryker announces definitive agreement to acquire Mobius Imaging & Cardan Robotics

    GlobeNewswire – 8:00 AM ET 09/04/2019

    Stryker announced today a definitive agreement to acquire Mobius Imaging, LLC, a leader in point-of-care imaging technology, and its sister company, GYS Tech, LLC, in an all cash transaction of approximately $370 million upfront and up to $130 million of contingent payments associated with development and commercial milestones.

  3. Show article details.

    Stryker to participate in Morgan Stanley 17th Annual Global Healthcare Conference

    GlobeNewswire – 10:35 AM ET 08/21/2019

    Stryker ) will participate in the Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, September 10, 2019 at the Grand Hyatt New York. Kevin Lobo, Chairman and Chief Executive Officer, will represent the Company in a presentation scheduled for 8:35 a.m. Eastern Time.

  4. Show article details.

    Philips, under investigation in U.S. and Brazil, fired whistleblower who warned of graft

    Reuters – 1:06 AM ET 08/21/2019

    Healthcare giant Philips was warned of suspicious sales of its medical equipment to the Brazilian government, and failed to halt them, nearly a decade before an alleged bribery racket was exposed in the company's Brazil operations last year, Reuters has learned.

  5. Show article details.

    Stryker announces commercial structure realignment

    GlobeNewswire – 4:00 PM ET 08/12/2019

    Stryker announced today an adjustment to its commercial organizational structure. Mr. Stiles and Mr. Pierce have both served at Stryker for over 20 years and will continue to report to Timothy J. Scannell, President and Chief Operating Officer in their newly expanded roles. Stuart F. Simpson, President of Joint Replacement has left the company to pursue other career interests.

  6. Show article details.

    BRIEF-Stryker Corp Declares A $0.52 Per Share Quarterly Dividend

    Reuters – 8:29 AM ET 07/31/2019

    Stryker Corp (SYK): * STRYKER DECLARES A $0.52 PER SHARE QUARTERLY DIVIDEND Source text for Eikon: Further company coverage:

  7. Show article details.

    Stryker declares a $0.52 per share quarterly dividend

    GlobeNewswire – 8:15 AM ET 07/31/2019

    Stryker announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on October 31, 2019 to shareholders of record at the close of business on September 30, 2019, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter.

  8. Stryker stock price target raised to $235 from $203 at CFRA

    MarketWatch – 11:10 AM ET 07/26/2019
  9. Show article details.

    BRIEF-Stryker Q2 Adjusted Earnings Per Share $1.98

    Reuters – 4:15 PM ET 07/25/2019

    Stryker Corp (SYK): * STRYKER REPORTS SECOND QUARTER 2019 OPERATING RESULTS. * SEES Q3 ADJUSTED EARNINGS PER SHARE $1.87 TO $1.92. * Q2 ADJUSTED EARNINGS PER SHARE $1.98. * Q2 EARNINGS PER SHARE $1.26. * Q2 SALES $3.7 BILLION VERSUS REFINITIV IBES ESTIMATE OF $3.6 BILLION. * Q2 EARNINGS PER SHARE ESTIMATE $1.94 -- REFINITIV IBES DATA.

  10. Show article details.

    Stryker reports second quarter 2019 operating results

    GlobeNewswire – 4:07 PM ET 07/25/2019

    Stryker reported operating results for the second quarter of 2019: Second Quarter Highlights "We are pleased with our second quarter performance, highlighted by 8.5% organic sales growth," said Kevin A. Lobo, Chairman and Chief Executive Officer. Sales Analysis Consolidated net sales of $3.7 billion increased 9.9% in the quarter and 11.5% in constant currency.

  11. Show article details.

    The S&P 500 just hit a record high -- so did these stocks

    MarketWatch – 6:52 AM ET 07/12/2019

    These 54 components of the S&P 500 rose to record levels too. Investors clearly find the U.S. stock market an attractive haven in a world of incredibly low interest rates. The S&P 500 Index hit an all-time intraday high on July 10, rising above 3,000 for the first time, before closing at 2,993.07, its second-highest close.

  12. Show article details.

    Stryker to host conference call on July 25, 2019

    GlobeNewswire – 2:30 PM ET 06/24/2019

    Stryker announced that it will host a conference call on Thursday, July 25, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2019 and provide an operational update. To participate in the conference call dial 702-4565 or 689-5532 and be prepared to provide conference ID number 5290408 to the operator.

  13. Show article details.

    Stryker to participate in Bank of America Merrill Lynch 2019 Health Care Conference

    GlobeNewswire – 3:00 PM ET 05/01/2019

    Stryker will participate in the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14, 2019 at the Encore at Wynn Hotel in Las Vegas, Nevada.  . Glenn Boehnlein, Vice President and Chief Financial Officer, will represent the Company in a presentation scheduled for 10:40 a.m. Pacific Time.

  14. Show article details.

    Stryker declares a $0.52 per share quarterly dividend

    GlobeNewswire – 8:00 AM ET 05/01/2019

    Stryker announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on July 31, 2019 to shareholders of record at the close of business on June 28, 2019, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter.

  15. Show article details.

    Stryker reports first quarter 2019 operating results

    GlobeNewswire – 4:05 PM ET 04/23/2019

    Stryker reported operating results for the first quarter of 2019: First Quarter Highlights "With over 7% organic sales growth in the first quarter, our multi-year momentum continued across our businesses and regions," said Kevin A. Lobo, Chairman and Chief Executive Officer. Sales Analysis Consolidated net sales of $3.5 billion increased 8.5% in the quarter and 10.6% in constant currency.

Page:

Today's and Upcoming Events

  • Oct
    23

    SYK to announce Q3 earnings (Unconfirmed)

  • Sep
    27

    SYK ex-Dividend for $0.52 on 09/27/2019

    • Announce Date: 07/31/2019
    • Record Date: 09/30/2019
    • Pay Date: 10/31/2019

Past Events (last 90 days)

  • Jul
    25

    SYK announced Q2 earnings.

  • Jun
    27

    SYK ex-Dividend for $0.52 on 06/27/2019

    • Announce Date: 05/01/2019
    • Record Date: 06/28/2019
    • Pay Date: 07/31/2019
Data provided by Thomson Reuters © 2019

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.